Literature DB >> 29182397

Breast tissue density change after oophorectomy in BRCA mutation carrier patients using visual and volumetric analysis.

Augustin Lecler1,2, Ariane Dunant3, Suzette Delaloge4, Delphine Wehrer5, Tania Moussa2, Olivier Caron5, Corinne Balleyguier2,6.   

Abstract

OBJECTIVE: BRCA1/2 mutations account for 30-50% of hereditary breast cancers and bilateral oophorectomy is associated with a reduced risk of breast cancer in these patients. Breast density is a well-established breast cancer risk factor and is also associated with increased risk in BRCA carriers. The aim of the study was to evaluate the impact of oophorectomy on mammographic breast density and to assess which method of breast density assessment is more sensitive to change over time.
METHODS: Retrospective study of 50 BRCA1/2 patients who underwent bilateral oophorectomy and had at least a baseline and post-surgery mammogram. Mammographic breast density was determined by Volpara and consensus visual assessment by two radiologists. The primary endpoint was change in density between baseline and the first mammogram post-surgery.
RESULTS: At baseline, there was a non-significant trend for decreased density with increasing age. Volumetric breast density (VBD) significantly decreased after oophorectomy from a median VBD of 12.5% at baseline to 10.2% post-surgery which was driven by a reduction in fibroglandular volume. There was a higher absolute decrease in VBD in patients aged between 40-50 (p < 0.01). Using Volpara Density Grades (analogous to BI-RADS 4th edition density categories), 84% of females displayed a decrease in density category over the study period compared to only 76% using the radiologists' visual classification (p < 0.001)
Conclusion: Oophorectomy is associated with a decrease in breast density and younger patients exhibit a larger absolute decrease. Volpara is more sensitive to identify change over time compared to visual assessment. Advances in knowledge: Oophorectomy is associated with a significant decrease in VBD in patients with BRCA mutations and Volpara Density Grades were more sensitive to identify decreases in density compared to visually assessed BI-RADS categories. Decreases in breast density following oophorectomy surgery in BRCA patients may be one of the mechanisms contributing to the observed decreased breast cancer risk after surgery. However, further studies are needed to investigate the relationship between breast density, oophorectomy and breast cancer risk in BRCA patients.

Entities:  

Mesh:

Year:  2018        PMID: 29182397      PMCID: PMC5965464          DOI: 10.1259/bjr.20170163

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  26 in total

Review 1.  Vision 20/20: Mammographic breast density and its clinical applications.

Authors:  Kwan-Hoong Ng; Susie Lau
Journal:  Med Phys       Date:  2015-12       Impact factor: 4.071

2.  Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories.

Authors:  S Ciatto; N Houssami; A Apruzzese; E Bassetti; B Brancato; F Carozzi; S Catarzi; M P Lamberini; G Marcelli; R Pellizzoni; B Pesce; G Risso; F Russo; A Scorsolini
Journal:  Breast       Date:  2005-08       Impact factor: 4.380

3.  Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.

Authors:  Kelly Metcalfe; Henry T Lynch; William D Foulkes; Nadine Tung; Charmaine Kim-Sing; Olufunmilayo I Olopade; Andrea Eisen; Barry Rosen; Carrie Snyder; Shelley Gershman; Ping Sun; Steven A Narod
Journal:  JAMA Oncol       Date:  2015-06       Impact factor: 31.777

4.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Authors:  J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

Review 5.  BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Authors:  P L Welcsh; M C King
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

6.  Reliability of automated breast density measurements.

Authors:  Olivier Alonzo-Proulx; Gordon E Mawdsley; James T Patrie; Martin J Yaffe; Jennifer A Harvey
Journal:  Radiology       Date:  2015-02-25       Impact factor: 11.105

7.  High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study.

Authors:  E Sala; R Warren; J McCann; S Duffy; R Luben; N Day
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

Review 8.  Hormones and mammographic breast density.

Authors:  Ruth Warren
Journal:  Maturitas       Date:  2004-09-24       Impact factor: 4.342

9.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  Gillian Mitchell; Antonis C Antoniou; Ruth Warren; Susan Peock; Judith Brown; Russell Davies; Jenny Mattison; Margaret Cook; Iqbal Warsi; D Gareth Evans; Diana Eccles; Fiona Douglas; Joan Paterson; Shirley Hodgson; Louise Izatt; Trevor Cole; Lucy Burgess; Ros Eeles; Douglas F Easton
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.